Personalis, Inc. (PSNL)
16.28
+0.11
(+0.68%)
USD |
NASDAQ |
Oct 02, 16:00
16.29
+0.01
(+0.06%)
After-Hours: 20:00
Personalis Gross Profit Margin (Quarterly) : 21.21% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.21% |
| March 31, 2026 | 1.82% |
| December 31, 2025 | 10.95% |
| September 30, 2025 | 13.20% |
| June 30, 2025 | 27.65% |
| March 31, 2025 | 34.98% |
| December 31, 2024 | 27.08% |
| September 30, 2024 | 34.02% |
| June 30, 2024 | 35.59% |
| March 31, 2024 | 28.13% |
| December 31, 2023 | 26.45% |
| September 30, 2023 | 19.08% |
| June 30, 2023 | 28.70% |
| March 31, 2023 | 25.08% |
| December 31, 2022 | 13.83% |
| September 30, 2022 | 16.68% |
| June 30, 2022 | 23.47% |
| Date | Value |
|---|---|
| March 31, 2022 | 28.09% |
| December 31, 2021 | 38.66% |
| September 30, 2021 | 36.23% |
| June 30, 2021 | 37.69% |
| March 31, 2021 | 35.57% |
| December 31, 2020 | 30.09% |
| September 30, 2020 | 26.91% |
| June 30, 2020 | 23.97% |
| March 31, 2020 | 21.08% |
| December 31, 2019 | 36.16% |
| September 30, 2019 | 32.82% |
| June 30, 2019 | 37.30% |
| March 31, 2019 | 28.31% |
| December 31, 2018 | 36.70% |
| September 30, 2018 | 38.45% |
| June 30, 2018 | 27.23% |
| March 31, 2018 | 2.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Tempus AI, Inc. | 63.54% |
| 10X Genomics, Inc. | 74.36% |
| Alamar Biosciences, Inc. (California) | 60.21% |
| Adaptive Biotechnologies Corp. | 70.15% |
| Champions Oncology, Inc. | 48.48% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.13% |
| Return on Assets | -36.38% |
| Return on Invested Capital | -40.72% |
| Profit Margin (Quarterly) | -141.7% |
| Operating Margin (Quarterly) | -150.2% |
| Return on Net Operating Assets | -132.1% |